Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 5.00
0.00 (0.00%)
Last updated: Sep 3, 2026, 1:50 PM CET
Read-Gene Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16.66 | 15.6 | 13.23 | 10.15 | 7.24 | 6.45 | |
Revenue Growth | 29.78% | 17.93% | 30.38% | 40.14% | 12.20% | 6.34% |
Cost of Revenue | 0.94 | 1 | 0.89 | 1.02 | 1.06 | 0.7 |
Gross Profit | 15.72 | 14.6 | 12.34 | 9.12 | 6.18 | 5.75 |
Selling, General & Admin | 14.24 | 13.58 | 12.19 | 9.71 | 5.37 | 5.3 |
Other Operating Expenses | 0.17 | 0.22 | 0.06 | 0.2 | 0.08 | -0.23 |
Operating Expenses | 14.87 | 14.25 | 12.73 | 10.4 | 5.9 | 5.64 |
Operating Income | 0.84 | 0.35 | -0.39 | -1.27 | 0.29 | 0.11 |
Interest Expense | -0.33 | -0.33 | -0.33 | -0.4 | -0.23 | -0.06 |
Interest & Investment Income | 0 | 0 | - | 0 | 0 | 0 |
Other Non Operating Income (Expenses) | -0 | -0 | -0.01 | -0 | -0 | -0 |
EBT Excluding Unusual Items | 0.51 | 0.02 | -0.73 | -1.67 | 0.06 | 0.05 |
Gain (Loss) on Sale of Investments | 0.1 | 0.1 | 0.15 | 0.05 | - | - |
Gain (Loss) on Sale of Assets | -0.04 | - | - | 0 | - | - |
Pretax Income | 0.56 | 0.12 | -0.58 | -1.62 | 0.06 | 0.05 |
Income Tax Expense | 0.05 | 0.02 | 0.53 | -0.28 | -0.15 | 0.01 |
Net Income | 0.51 | 0.1 | -1.11 | -1.35 | 0.21 | 0.04 |
Net Income to Common | 0.51 | 0.1 | -1.11 | -1.35 | 0.21 | 0.04 |
Net Income Growth | - | - | - | - | 462.78% | -89.15% |
Shares Outstanding (Basic) | - | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | - | 12 | 12 | 12 | 12 | 12 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | - | 0.01 | -0.09 | -0.11 | 0.02 | 0.00 |
EPS (Diluted) | - | 0.01 | -0.09 | -0.11 | 0.02 | 0.00 |
EPS Growth | - | - | - | - | 462.87% | -89.15% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.2 | -0.45 | 1.75 | -1.18 | 0.33 | 0.05 |
Free Cash Flow Per Share | - | -0.04 | 0.15 | -0.10 | 0.03 | 0.00 |
Gross Margin | 94.35% | 93.56% | 93.27% | 89.91% | 85.41% | 89.09% |
Operating Margin | 5.06% | 2.26% | -2.95% | -12.54% | 3.95% | 1.76% |
Profit Margin | 3.08% | 0.62% | -8.40% | -13.27% | 2.94% | 0.59% |
Free Cash Flow Margin | -19.22% | -2.90% | 13.25% | -11.65% | 4.61% | 0.71% |
EBITDA | 1.31 | 0.81 | 0.09 | -0.78 | 0.74 | 0.67 |
EBITDA Margin | 7.85% | 5.16% | 0.69% | -7.68% | 10.25% | 10.44% |
D&A For EBITDA | 0.46 | 0.45 | 0.48 | 0.49 | 0.46 | 0.56 |
EBIT | 0.84 | 0.35 | -0.39 | -1.27 | 0.29 | 0.11 |
EBIT Margin | 5.06% | 2.26% | -2.95% | -12.54% | 3.95% | 1.76% |
Effective Tax Rate | 8.90% | 15.98% | - | - | - | 27.93% |
Revenue as Reported | 16.66 | 15.6 | 13.23 | 10.15 | 7.24 | 6.45 |